Literature DB >> 10503908

New insights into carcinogenesis of the classical model arylamine 2-acetylaminofluorene.

A Bitsch1, P C Klöhn, N Hadjiolov, O Bergmann, H G Neumann.   

Abstract

2-Acetylaminofluorene (AAF) is a complete carcinogen in rat liver. The genotoxic effects of reactive metabolites are considered necessary but not sufficient to explain tumor formation. An overview is given of an AAF-feeding experiment designed to demonstrate early effects, preceding the development of enzyme-altered foci to support the hypothesis that toxic effects lead to a cirrhosis-like transformation as a prerequisite for the expansion of initiated foci and how those effects influence the dose-time-response relationship of tumor formation. Male Wistar rats were fed 0.005, 0.01, 0.02, 0.04 and 0.08% AAF in the diet for 2, 4, 8, and 16 weeks. GST-P-positive foci developed more than proportionately only at 16 weeks. As a first sign of morphological alterations the number of apoptoses increased (2 weeks), the proliferation rate followed with some delay and was maximal at 4 weeks. The most sensitive parameter for adaptive responses was the inhibition of the mitochondrial permeability transition, studied ex vivo. All parameters increased dose-dependently at low doses. A threshold could not be detected, but effects developed much more gradually with the lowest, non-toxic dose. The situation of massive development of foci observed with the higher doses at 16 weeks was not reached. Apoptosis and proliferation rate reach a plateau between 4 and 8 weeks with some of the doses indicating a period in which some balance between adaptation and stress response exists.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10503908     DOI: 10.1016/s0304-3835(99)00129-9

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  2 in total

1.  MicroRNA-152-mediated dysregulation of hepatic transferrin receptor 1 in liver carcinogenesis.

Authors:  Iryna Kindrat; Volodymyr Tryndyak; Aline de Conti; Svitlana Shpyleva; Thilak K Mudalige; Tetyana Kobets; Anna M Erstenyuk; Frederick A Beland; Igor P Pogribny
Journal:  Oncotarget       Date:  2016-01-12

2.  Early resistance to cell death and to onset of the mitochondrial permeability transition during hepatocarcinogenesis with 2-acetylaminofluorene.

Authors:  Peter-Christian Klöhn; Maria Eugenia Soriano; William Irwin; Daniele Penzo; Luca Scorrano; Annette Bitsch; Hans-Günter Neumann; Paolo Bernardi
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-07       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.